Oxybutynin Chloride Tablet
Product Images NDC 23155-913

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 23155-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5 mg-100's (5 mg 100s)

5 mg-100's (5 mg 100s)
The image shows a label for Oxybutynin Chloride Tablets USP, 5 mg, oral tablets. The label indicates a package containing 100 tablets and is marked Rx only. The labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc., with NDC number 23155-913-01. Additional text includes dosage instructions, warnings, storage conditions, barcode, and revision date.*
FDA Label Image

5 mg-1000's (5 mg 1000s)

5 mg-1000's (5 mg 1000s)
Oxybutynin Chloride Tablets USP 5 mg oral tablets label showing 1000 tablets per container. The label includes dosage warnings, storage instructions, the Avet Pharma logo, and a barcode. The labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.*
FDA Label Image

5 mg-500's (5 mg 500s)

5 mg-500's (5 mg 500s)
Oxybutynin Chloride Tablets USP, 5 mg oral tablets, in a package of 500 tablets. The label states the product is Rx only and includes handling instructions such as storage conditions and child safety warnings. The labeler is Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.*
FDA Label Image

Structure (880d1d3d 0070 4177 Bc63 9fdc66507f27 01)

Structure (880d1d3d 0070 4177 Bc63 9fdc66507f27 01)
Chemical structure of oxybutynin chloride, showing its molecular components including a phenyl group, hydroxyl group, ester linkage, alkyne, and a dimethylaminoethyl side chain with hydrochloride.*
FDA Label Image

Graph (880d1d3d 0070 4177 Bc63 9fdc66507f27 02)

Graph (880d1d3d 0070 4177 Bc63 9fdc66507f27 02)
A line graph depicting mean plasma R-oxybutynin concentration (ng/mL) over 24 hours following oral administration of oxybutynin 5 mg taken three times daily (TID). The x-axis shows time in hours from 0 to 24, and the y-axis shows concentration levels ranging from 0 to 5 ng/mL, with error bars indicating variability at each time point.*
FDA Label Image

Graph2 (880d1d3d 0070 4177 Bc63 9fdc66507f27 03)

Graph2 (880d1d3d 0070 4177 Bc63 9fdc66507f27 03)
A line graph depicting mean R-oxybutynin plasma concentration (ng/mL) over time (hours). The x-axis represents time from 0 to 12 hours, and the y-axis shows concentration from 0 to 10 ng/mL. Data points with error bars indicate a peak concentration around 1 hour, followed by a gradual decline to near baseline by 12 hours.*
FDA Label Image

Logo (880d1d3d 0070 4177 Bc63 9fdc66507f27 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.